ANDERSSON, Emma R., Indira V. CHIVUKULA, Simona HANKEOVÁ, Marika SJOQVIST, Yat Long TSOI, Daniel RAMSKOLD, Jan MASEK, Aiman ELMANSURI, Anita HOOGENDOORN, Elenae VAZQUEZ, Helena STORVALL, Julie NETUŠILOVÁ, Meritxell HUCH, Bjorn FISCHLER, Ewa ELLIS, Adriana CONTRERAS, Antal NEMETH, Kenneth C. CHIEN, Hans CLEVERS, Rickard SANDBERG, Vítězslav BRYJA a Urban LENDAHL. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations. Gastroenterology. Philadelphia: W B Saunders co-Elsevier Inc, 2018, roč. 154, č. 4, s. 1080-1095. ISSN 0016-5085. Dostupné z: https://dx.doi.org/10.1053/j.gastro.2017.11.002.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations
Autoři ANDERSSON, Emma R., Indira V. CHIVUKULA, Simona HANKEOVÁ (203 Česká republika, domácí), Marika SJOQVIST, Yat Long TSOI, Daniel RAMSKOLD, Jan MASEK, Aiman ELMANSURI, Anita HOOGENDOORN, Elenae VAZQUEZ, Helena STORVALL, Julie NETUŠILOVÁ (203 Česká republika, domácí), Meritxell HUCH, Bjorn FISCHLER, Ewa ELLIS, Adriana CONTRERAS, Antal NEMETH, Kenneth C. CHIEN, Hans CLEVERS, Rickard SANDBERG, Vítězslav BRYJA (203 Česká republika, garant, domácí) a Urban LENDAHL.
Vydání Gastroenterology, Philadelphia, W B Saunders co-Elsevier Inc, 2018, 0016-5085.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW Full Text
Impakt faktor Impact factor: 19.809
Kód RIV RIV/00216224:14310/18:00113255
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1053/j.gastro.2017.11.002
UT WoS 000427453300047
Klíčová slova anglicky Notch; Jagged1; Alagille; Heart; Liver; Kidney; Vertebrae; Development
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 13. 3. 2020 15:55.
Anotace
BACKGROUND & AIMS: Alagille syndrome is a genetic disorder characterized by cholestasis, ocular abnormalities, characteristic facial features, heart defects, and vertebral malformations. Most cases are associated with mutations in JAGGED1 (JAG1), which encodes a Notch ligand, although it is not clear how these contribute to disease development. We aimed to develop a mouse model of Alagille syndrome to elucidate these mechanisms. METHODS: Mice with a missense mutation (H268Q) in Jag1 (Jag1(+/Ndr) mice) were outbred to a C3H/C57bl6 background to generate a mouse model for Alagille syndrome (Jag1(Ndr/Ndr) mice). Liver tissues were collected at different timepoints during development, analyzed by histology, and liver organoids were cultured and analyzed. We performed transcriptome analysis of Jag1(Ndr/Ndr) livers and livers from patients with Alagille syndrome, cross-referenced to the Human Protein Atlas, to identify commonly dysregulated pathways and biliary markers. We used species-specific transcriptome separation and ligand-receptor interaction assays to measure Notch signaling and the ability of JAG1(Ndr) to bind or activate Notch receptors. We studied signaling of JAG1 and JAG1(Ndr) via NOTCH 1, NOTCH2, and NOTCH3 and resulting gene expression patterns in parental and NOTCH1-expressing C2C12 cell lines. RESULTS: Jag1(Ndr/Ndr) mice had many features of Alagille syndrome, including eye, heart, and liver defects. Bile duct differentiation, morphogenesis, and function were dysregulated in newborn Jag1(Ndr/Ndr) mice, with aberrations in cholangiocyte polarity, but these defects improved in adult mice. Jag1(Ndr/Ndr) liver organoids collapsed in culture, indicating structural instability. Whole-transcriptome sequence analyses of liver tissues from mice and patients with Alagille syndrome identified dysregulated genes encoding proteins enriched at the apical side of cholangiocytes,including CFTR and SLC5A1, as well as reduced expression of IGF1. Exposure of Notch-expressing cells to JAG1(Ndr), compared with JAG1, led to hypomorphic Notch signaling, based on transcriptome analysis. JAG1-expressing cells, but not JAG1(Ndr)-expressing cells, bound soluble Notch1 extracellular domain, quantified by flow cytometry. However, JAG1 and JAG1(Ndr) cells each bound NOTCH2, and signaling from NOTCH2 signaling was reduced but not completely inhibited, in response to JAG1(Ndr) compared with JAG1. CONCLUSIONS: In mice, expression of a missense mutant of Jag1 (Jag1(Ndr)) disrupts bile duct development and recapitulates Alagille syndrome phenotypes in heart, eye, and craniofacial dysmorphology. JAG1(Ndr) does not bind NOTCH1, but binds NOTCH2, and elicits hypomorphic signaling. This mouse model can be used to study other features of Alagille syndrome and organ development.
VytisknoutZobrazeno: 14. 5. 2024 11:11